Quarterly report pursuant to Section 13 or 15(d)

Schedule of Proforma Condensed Consolidated Financials (Details)

v3.24.2.u1
Schedule of Proforma Condensed Consolidated Financials (Details) - USD ($)
 6 Months Ended
Jun. 30, 2024
Jun. 29, 2024
Mar. 31, 2024
Mar. 04, 2024
Feb. 14, 2024
Feb. 13, 2024
Dec. 31, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Current Assets                    
Cash $ 536,026           $ 2,681,010      
Marketable Securities 12,530,326           2,242,106      
Prepaid expenses 1,291,380           893,226      
Total Current Assets 14,357,732           5,816,342      
Non-Current Assets                    
Lease Right-of-Use 25,803           47,389      
Goodwill 10,498,539           10,498,539      
Investment in Oravax Medical 1,500,000                  
Total Non-Current Assets 12,024,342           12,045,928      
Total Assets 26,382,074           17,862,270      
Current Liabilities                    
Trade and Other Payables 4,616,513           3,716,218      
Deferred Compensation Payable 331,992                  
Due to MyMD FL Shareholders 29,982                  
Lease Liability 25,803           48,870      
Dividends Payable 778,491           265,019      
Derivative Liability           61,000      
Warrant Liability           867,000      
Total Current Liabilities 5,782,781           4,988,089      
Non-Current Liabilities                    
Deferred Compensation Payable, net of current           100,538      
Derivative Liability, net of current 926,000                  
Warrant Liability, net of current 19,291,000                  
Total Non-Current Liabilities 20,217,000           100,538      
Total Liabilities 25,999,781           5,088,627      
Commitments and Contingencies                
Mezzanine Equity                    
Total Mezzanine Equity $ 284,488           $ 404,071      
STOCKHOLDERS’ EQUITY                    
Preferred stock, par value $ 0.001           $ 0.001      
Preferred stock, shares authorized 50,000,000           50,000,000      
Common Stock, par value $0.001, 250,000,000 shares authorized 2,370,423 and 2,018,857 shares issued and outstanding as of June 30, 2024 and December 31, 2023 $ 2,370           $ 2,019      
Common stock, par value $ 0.001     $ 0.001     $ 0.001      
Common stock, shares authorized 250,000,000       66,666,666 550,000,000 250,000,000      
Common stock, shares issued 2,370,423           2,018,857      
Common stock, shares outstanding 2,370,423           2,018,857      
Additional Paid in Capital $ 123,272,874           $ 114,200,096      
Accumulated Deficit (123,321,963)           (101,977,067)      
Total Stockholders’ Equity 97,805 $ 97,805 $ 9,937,592       12,369,572 $ 10,741,770 $ 13,094,059 $ 14,695,056
Total Liabilities, Mezzanine Equity, and Stockholders’ Equity 26,382,074           17,862,270      
Series F Convertible Preferred Stock [Member]                    
Mezzanine Equity                    
Redeemable Preferred Stock, value $ 4,576,553           $ 6,500,278      
Temporary equity shares, authorized 15,000           15,000      
Temporary stock, par value $ 0.001           $ 0.001      
Temporary stock, par value $ 1,000           $ 1,000      
Temporary stock, shares outstanding 4,675           6,633      
Temporary stock, shares issued 4,675           6,633      
Temporary equity, liquidation preference $ 4,675,000                  
Temporary stock dividend rate percentage 10.00%                  
Temporary stock dividend $ 626,553                  
Temporary Preferred Stock Discount, value (3,310,483)           $ (4,702,023)      
Temporay Preferred stock Derivative, value (981,582)           (1,394,184)      
Series F-1 Convertible Preferred Stock [Member]                    
Mezzanine Equity                    
Redeemable Preferred Stock, value $ 5,050,000                
Temporary equity shares, authorized 5,050           5,050      
Temporary stock, par value $ 0.001           $ 0.001      
Temporary stock, par value $ 1,000           $ 1,000      
Temporary stock, shares outstanding 5,050           0      
Temporary stock, shares issued 5,050           0      
Temporary equity, liquidation preference $ 5,050,000                  
Temporary stock dividend rate percentage 10.00%                  
Temporary stock dividend $ 54,813                  
Temporary Preferred Stock Discount, value (5,050,000)                
Temporay Preferred stock Derivative, value                  
Series G Convertible Preferred Stock [Member]                    
Mezzanine Equity                    
Redeemable Preferred Stock, value $ 8,950,000                
Temporary equity shares, authorized 12,826,273           12,826,273      
Temporary stock, par value $ 0.001           $ 0.001      
Temporary stock, par value $ 1,000           $ 1,000      
Temporary stock, shares outstanding 8,950           0      
Temporary stock, shares issued 8,950           0      
Temporary equity, liquidation preference $ 8,950,000                  
Temporary stock dividend rate percentage 10.00%                  
Temporary stock dividend $ 97,145                  
Temporary Preferred Stock Discount, value (8,950,000)                
Series D Convertible Preferred Stock [Member]                    
STOCKHOLDERS’ EQUITY                    
Preferred stock, value $ 144,524           $ 144,524      
Preferred stock, par value $ 0.001           $ 0.001      
Preferred stock, shares authorized 211,353           211,353      
[custom:PreferredStockStatedValue-0] $ 0.01           $ 0.01      
Preferred Stock, Shares Outstanding 72,992           72,992      
Preferred Stock, Shares Issued 72,992           72,992      
Revision of Prior Period, Reclassification, Adjustment [Member]                    
Current Assets                    
Cash                  
Marketable Securities                  
Prepaid expenses                  
Total Current Assets                  
Non-Current Assets                    
Lease Right-of-Use                  
Goodwill                  
Investment in Oravax Medical                  
Total Non-Current Assets                  
Total Assets                  
Current Liabilities                    
Trade and Other Payables                  
Deferred Compensation Payable                  
Due to MyMD FL Shareholders                  
Lease Liability                  
Dividends Payable                  
Derivative Liability                  
Warrant Liability                  
Total Current Liabilities                  
Non-Current Liabilities                    
Deferred Compensation Payable, net of current                  
Derivative Liability, net of current                  
Warrant Liability, net of current (19,291,000)                  
Total Non-Current Liabilities (19,291,000)                  
Total Liabilities (19,291,000)                  
Commitments and Contingencies                  
Mezzanine Equity                    
Total Mezzanine Equity                  
STOCKHOLDERS’ EQUITY                    
Common Stock, par value $0.001, 250,000,000 shares authorized 2,370,423 and 2,018,857 shares issued and outstanding as of June 30, 2024 and December 31, 2023                  
Additional Paid in Capital 19,291,000                  
Accumulated Deficit                  
Total Stockholders’ Equity 19,291,000                  
Total Liabilities, Mezzanine Equity, and Stockholders’ Equity                  
Revision of Prior Period, Reclassification, Adjustment [Member] | Series F Convertible Preferred Stock [Member]                    
Mezzanine Equity                    
Redeemable Preferred Stock, value                  
Temporary Preferred Stock Discount, value                  
Temporay Preferred stock Derivative, value                  
Revision of Prior Period, Reclassification, Adjustment [Member] | Series F-1 Convertible Preferred Stock [Member]                    
Mezzanine Equity                    
Redeemable Preferred Stock, value                  
Temporary Preferred Stock Discount, value                  
Temporay Preferred stock Derivative, value                  
Revision of Prior Period, Reclassification, Adjustment [Member] | Series G Convertible Preferred Stock [Member]                    
Mezzanine Equity                    
Redeemable Preferred Stock, value                  
Temporary Preferred Stock Discount, value                  
Revision of Prior Period, Reclassification, Adjustment [Member] | Series D Convertible Preferred Stock [Member]                    
STOCKHOLDERS’ EQUITY                    
Preferred stock, value                  
Previously Reported [Member]                    
Current Assets                    
Cash 536,026                  
Marketable Securities 12,530,326                  
Prepaid expenses 1,291,380                  
Total Current Assets 14,357,732                  
Non-Current Assets                    
Lease Right-of-Use 25,803                  
Goodwill 10,498,539                  
Investment in Oravax Medical 1,500,000                  
Total Non-Current Assets 12,024,342                  
Total Assets 26,382,074                  
Current Liabilities                    
Trade and Other Payables 4,616,513                  
Deferred Compensation Payable 331,992                  
Due to MyMD FL Shareholders 29,982                  
Lease Liability 25,803                  
Dividends Payable 778,491                  
Derivative Liability                  
Warrant Liability                  
Total Current Liabilities 5,782,781                  
Non-Current Liabilities                    
Deferred Compensation Payable, net of current                  
Derivative Liability, net of current 926,000                  
Warrant Liability, net of current                  
Total Non-Current Liabilities 926,000                  
Total Liabilities 6,708,781                  
Commitments and Contingencies                  
Mezzanine Equity                    
Total Mezzanine Equity 284,488                  
STOCKHOLDERS’ EQUITY                    
Common Stock, par value $0.001, 250,000,000 shares authorized 2,370,423 and 2,018,857 shares issued and outstanding as of June 30, 2024 and December 31, 2023 2,370                  
Additional Paid in Capital 142,563,874                  
Accumulated Deficit (123,321,963)                  
Total Stockholders’ Equity 19,405,805                  
Total Liabilities, Mezzanine Equity, and Stockholders’ Equity 26,382,074                  
Previously Reported [Member] | Series F Convertible Preferred Stock [Member]                    
Mezzanine Equity                    
Redeemable Preferred Stock, value 4,576,553                  
Temporary Preferred Stock Discount, value (3,310,483)                  
Temporay Preferred stock Derivative, value (981,582)                  
Previously Reported [Member] | Series F-1 Convertible Preferred Stock [Member]                    
Mezzanine Equity                    
Redeemable Preferred Stock, value 5,050,000                  
Temporary Preferred Stock Discount, value (5,050,000)                  
Temporay Preferred stock Derivative, value                  
Previously Reported [Member] | Series G Convertible Preferred Stock [Member]                    
Mezzanine Equity                    
Redeemable Preferred Stock, value 8,950,000                  
Temporary Preferred Stock Discount, value (8,950,000)                  
Previously Reported [Member] | Series D Convertible Preferred Stock [Member]                    
STOCKHOLDERS’ EQUITY                    
Preferred stock, value $ 144,524